Procter & Gamble is buying supplement brand Thorne for $3.8 billion, CEO Shailesh Jejurikar said on CNBC’s “Squawk on the Street.”
The acquisition, which is set to be announced Tuesday, is a bid for P&G to grow its health and wellness division. The consumer goods giant already owns other health brands, like Vick’s and Oral-B.
“We are really happy with the asset itself,” Jejurikar told CNBC’s Sara Eisen. “It’s a really well-run operation, and it’s been around for a long time.”
Thorne’s Magnesium Glycinate and Ginseng Plus supplements.
Courtesy: Thorne
The supplement brand was founded in 1984 and went public in late 2021 at a valuation of $525 million. L Catterton then took the company private in 2023 in a deal valued at $680 million. Its annual revenue surpassed $500 million in 2025, according to Thorne.
Thorne CEO Colin Watts told CNBC earlier this year that it had the potential to become a billion dollar brand within the next few years.
The majority of Thorne’s revenue comes from shoppers under the age of 40. The supplement brand has also seen a surge in direct-to-consumer sales.
Shares of P&G were trading up less than 1% in morning trading on Tuesday.
— CNBC’s Gabrielle Fonrouge contributed to this report
This is breaking news. Please refresh for updates.
